Abstract
Schizophrenia (SZ) is an inheritable complex mental disease. There have been several genome-wide association studies (GWASs) of SZ to identify novel genetic susceptibility factors. To further interpret SZ GWASs, pathway-based analysis (PBA), which considers the combined effect of variants and identifies pathways associated with traits, provides a feasible solution to discover the biological function and mechanism of SZ. Furthermore, to investigate the common pathways between SZ and bipolar disorder (BD) will help explore common mechanism between psychiatric phenotypes. We performed a PBA, called improved gene set enrichment analysis (i-GSEA), on 3 independent GWASs of SZ to identify pathways associated with SZ. The results were further compared to the BD-associated pathways identified by i-GSEA for 2 BD GWASs and from literature reports. Our analysis identified a highly statistically significant association between SZ and pathway ‘substrate specific channel activity’ in all 3 SZ GWASs (false discovery rate (FDR) < 0.05). This association has not been reported elsewhere before. This pathway was also identified by PBA for 2 independent BD GWASs. Our results suggest that pathway ‘substrate specific channel activity’ is statistically significantly associated with SZ, and SZ and BD share the common biological function and mechanism represented by this pathway.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Perala J, Suvisaari J, Saarni S I, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry, 2007, 64: 19–28
Saha S, Chant D, Welham J, et al. A systematic review of the prevalence of schizophrenia. PLoS Med, 2005, 2: e141
Cardno A G, Gottesman I I. Twin studies of schizophrenia: From bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet, 2000, 97: 12–17
McCarthy M I, Abecasis G R, Cardon L R, et al. Genome-wide association studies for complex traits: Consensus, uncertainty and challenges. Nat Rev Genet, 2008, 9: 356–369
Hindorff L A, Sethupathy P, Junkins H A, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA, 2009, 106: 9362–9367
Lencz T, Morgan T V, Athanasiou M, et al. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry, 2007, 12: 572–580
O’Donovan M C, Craddock N, Norton N, et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet, 2008, 40: 1053–1055
Shifman S, Johannesson M, Bronstein M, et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet, 2008, 4: e28
Sullivan P F, Lin D, Tzeng J Y, et al. Genomewide association for schizophrenia in the CATIE study: Results of stage 1. Mol Psychiatry, 2008, 13: 570–584
Kirov G, Zaharieva I, Georgieva L, et al. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol Psychiatry, 2009, 14: 796–803
Need A C, Ge D, Weale M E, et al. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet, 2009, 5: e1000373
Purcell S M, Wray N R, Stone J L, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 2009, 460: 748–752
Shi J, Levinson D F, Duan J, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature, 2009, 460: 753–757
Stefansson H, Ophoff R A, Steinberg S, et al. Common variants conferring risk of schizophrenia. Nature, 2009, 460: 744–747
Nam D, Kim S Y. Gene-set approach for expression pattern analysis. Brief Bioinform, 2008, 9: 189–197
Wang K, Li M, Bucan M. Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet, 2007, 81: 1278–1283
Cantor R M, Lange K, Sinsheimer J S. Prioritizing GWAS results: A review of statistical methods and recommendations for their application. Am J Hum Genet, 2010, 86: 6–22
Wang K, Li M, Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat Rev Genet, 2010, 11: 843–854
Zhang K, Cui S, Chang S, et al. i-GSEA4GWAS: A web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study. Nucleic Acids Res, 2010, 38(Suppl): W90–W95
Craddock N, O’Donovan M C, Owen M J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull, 2006, 32: 9–16
Kanehisa M, Goto S, Furumichi M, et al. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res, 2010, 38: D355–D360
Ashburner M, Ball C A, Blake J A, et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet, 2000, 25: 25–29
Subramanian A, Tamayo P, Mootha V K, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA, 2005, 102: 15545–15550
Torkamani A, Topol E J, Schork N J. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics, 2008, 92: 265–272
Chen L, Zhang L, Zhao Y, et al. Prioritizing risk pathways: A novel association approach to searching for disease pathways fusing SNPs and pathways. Bioinformatics, 2009, 25: 237–242
Peng G, Luo L, Siu H, et al. Gene and pathway-based second-wave analysis of genome-wide association studies. Eur J Hum Genet, 2010, 18: 111–117
O’Dushlaine C, Kenny E, Heron E, et al. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry, 2011, 16: 286–292
Askland K, Read C, Moore J. Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission. Hum Genet, 2009, 125: 63–79
Holmans P, Green E K, Pahwa J S, et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet, 2009, 85: 13–24
The Wellcome Trust Case Control Consortium. Genome-wide association study of 14000 cases of seven common diseases and 3000 shared controls. Nature, 2007, 447: 661–678
Sklar P, Smoller J W, Fan J, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry, 2008, 13: 558–569
Ferreira M A, O’Donovan M C, Meng Y A, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet, 2008, 40: 1056–1058
Flicek P, Aken B L, Ballester B, et al. Ensembl’s 10th year. Nucleic Acids Res, 2010, 38: D557–D562
Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics, 2003, 19: 368–375
Jia P, Wang L, Meltzer H Y, et al. Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data. Schizophr Res, 2010, 122: 38–42
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Zhang, K., Zhang, L., Zhang, W. et al. Pathway-based analysis for genome-wide association studies of schizophrenia to provide new insight in schizophrenia study. Chin. Sci. Bull. 56, 3398–3402 (2011). https://doi.org/10.1007/s11434-011-4742-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-011-4742-2